Latest Options News

Mount Ridley Mines’ first TIMA automated mineralogy study at Grass Patch reveals rare earth elements are locked in discrete phosphate minerals, supporting flotation as a key beneficiation step ahead of leaching and Phase 1 metallurgical testwork.

Flynn Gold has inked a non-binding Ore Purchase Agreement with Kaiser Reef's Henty Gold Mine, opening a potential low-capital route to production for its Golden Ridge project in Tasmania.

iTech Minerals has delivered a standout drill intercept of 36m at 5.6 g/t gold and 1.2% antimony at its Sabre Prospect in the Northern Territory, reinforcing the potential scale and grade of the Reynolds Range Project.

Norwest Minerals has completed a partly underwritten entitlement offer, securing $1.89 million to fund exploration and development at its Bulgera Gold Project.

Hawsons Iron (ASX:HIO) is aiming to raise up to A$1.5 million through a discounted Share Purchase Plan, sweetened with free attaching unlisted options exercisable at A$0.015 each.

Evolution Mining plans to release its FY26 financial results on 19 August, highlighting 715koz gold and 66kt copper production with robust cash flow and cost metrics.

ClearVue Technologies has secured Clean Energy Council approval for its ClearVue-Helios rooftop solar panels, enabling government subsidies and grid connection in Australia. This certification coincides with expanded commercial solar incentives, potentially lowering costs for customers.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Promisia Healthcare is set to acquire Chatswood Retirement Village in Christchurch for $25 million, bolstering its East Christchurch presence and promising immediate earnings accretion.

Infinity Metals has locked in an exclusive option to acquire 100% of the Tule Canyon molybdenum-copper project in Nevada, a historically explored porphyry deposit with promising drill results and strategic positioning amid soaring molybdenum prices.

Heavy Rare Earths Limited (ASX:HRE) has secured $2.028 million through a placement and entitlement offer to advance drilling programs and a strategic review across its key projects in South Australia and Western Australia.

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.